{
    "Symbol": "LLY",
    "AssetType": "Common Stock",
    "Name": "Eli Lilly and Company",
    "Description": "Eli Lilly and Company is an American pharmaceutical company headquartered in Indianapolis, Indiana, with offices in 18 countries. Its products are sold in approximately 125 countries.",
    "CIK": "59478",
    "Exchange": "NYSE",
    "Currency": "USD",
    "Country": "USA",
    "Sector": "LIFE SCIENCES",
    "Industry": "PHARMACEUTICAL PREPARATIONS",
    "Address": "LILLY CORPORATE CTR, DROP CODE 1094, INDIANAPOLIS, IN, US",
    "FiscalYearEnd": "December",
    "LatestQuarter": "2022-12-31",
    "MarketCapitalization": "296389444000",
    "EBITDA": "10175800000",
    "PERatio": "45.1",
    "PEGRatio": "2.181",
    "BookValue": "11.83",
    "DividendPerShare": "3.92",
    "DividendYield": "0.0143",
    "EPS": "6.9",
    "RevenuePerShareTTM": "31.65",
    "ProfitMargin": "0.219",
    "OperatingMarginTTM": "0.303",
    "ReturnOnAssetsTTM": "0.11",
    "ReturnOnEquityTTM": "0.627",
    "RevenueTTM": "28541399000",
    "GrossProfitTTM": "21911600000",
    "DilutedEPSTTM": "6.9",
    "QuarterlyEarningsGrowthYOY": "0.13",
    "QuarterlyRevenueGrowthYOY": "-0.087",
    "AnalystTargetPrice": "383.62",
    "TrailingPE": "45.1",
    "ForwardPE": "39.06",
    "PriceToSalesRatioTTM": "11.7",
    "PriceToBookRatio": "34.06",
    "EVToRevenue": "12.18",
    "EVToEBITDA": "42.04",
    "Beta": "0.349",
    "52WeekHigh": "383.2",
    "52WeekLow": "251.23",
    "50DayMovingAverage": "348.92",
    "200DayMovingAverage": "331.73",
    "SharesOutstanding": "950296000",
    "DividendDate": "2023-03-10",
    "ExDividendDate": "2023-02-14"
}